文献速递泌尿生殖骨肌MR

髋关节假体中重度磁敏感伪影导致前列腺MRI癌症检出率下降

Decreased prostate MRI cancer detection rate due to moderate to severe susceptibility artifacts from hip prosthesis.
PubMed 文献 · Eur Radiol · 2023-10-27

这项三中心回顾性研究纳入2017至2021年无已知前列腺癌患者的前列腺MRI,评估髋关节假体磁敏感伪影对癌症检出率(CDR)的影响。中度至重度伪影病例的CDR较匹配对照降低至74%(CDR比值0.74,95%CI 0.58-0.93),主要归因于PI-RADS 1-2比例增加。作者认为当PI-RADS 1-2时可考虑扩大系统性前列腺活检适应证。

要点

  • 中度至重度髋关节假体磁敏感伪影使前列腺MRI癌症检出率降至匹配对照的74%。
  • CDR下降主要归因于PI-RADS 1-2频率增加,而非PI-RADS≥3病灶漏诊。
  • 当PI-RADS 1-2时,作者认为可考虑扩大系统性前列腺活检的适应证。

核心结论

  • 中度至重度髋关节假体磁敏感伪影使前列腺MRI癌症检出率降至匹配对照的74%(CDR比值0.74,95%CI 0.58-0.93),主要归因于PI-RADS 1-2频率增加。

研究设计与样本

  • 三中心回顾性研究,纳入2017至2021年无已知前列腺癌患者的前列腺MRI检查共11,319例,其中548例(4.8%)存在髋关节假体;对每个伪影等级按1:6匹配无假体对照,由盲法阅片者将扩散加权图像上伪影程度分为轻度(可评估前列腺体积>66%)、中度(33-66%)和重度(<33%)。

关键影像表现/征象

  • 轻度伪影组(n=238)CDR为0.27,匹配对照为0.25,CDR比值1.09(95%CI 0.87-1.37)。
  • 中度伪影组(n=143)CDR为0.18,匹配对照为0.27,CDR比值0.67(95%CI 0.46-0.96)。
  • 重度伪影组(n=167)CDR为0.22,匹配对照为0.28,CDR比值0.80(95%CI 0.59-1.08)。
  • 中度和重度伪影合并后CDR比值为0.74(95%CI 0.58-0.93)。
  • CDR下降主要归因于PI-RADS 1-2频率增加。

诊断标准与关键数值

  • CDR定义为MRI检出Gleason评分≥7(PI-RADS≥3)的检查数除以总检查数。
  • 伪影分级基于扩散加权图像上可评估前列腺体积比例:轻度>66%,中度33-66%,重度<33%。
  • 中度伪影组CDR比值0.67(95%CI 0.46-0.96),重度伪影组CDR比值0.80(95%CI 0.59-1.08),合并后CDR比值0.74(95%CI 0.58-0.93)。

临床应用与阅片要点

  • 当PI-RADS 1-2且存在中度至重度髋关节假体磁敏感伪影时,作者认为可考虑扩大系统性前列腺活检的适应证。
  • 中度至重度髋关节假体磁敏感伪影可能造成不可忽视的前列腺MRI癌症检出率下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the impact of susceptibility artifacts from hip prosthesis on cancer detection rate (CDR) in prostate MRI.

MATERIALS AND METHODS: This three-center retrospective study included prostate MRI studies for patients without known prostate cancer between 2017 and 2021. Exams with hip prosthesis were searched on MRI reports. The degree of susceptibility artifact on diffusion-weighted images was retrospectively categorized into mild, moderate, and severe (> 66%, 33-66%, and < 33% of the prostate volume are evaluable) by blind reviewers. CDR was defined as the number of exams with Gleason score ≥7 detected by MRI (PI-RADS ≥3) divided by the total number of exams. For each artifact grade, control exams without hip prosthesis were matched (1:6 match), and CDR was compared. The degree of CDR reduction was evaluated with ratio, and influential factors were evaluated by expanding the equation.

RESULTS: Hip arthroplasty was present in 548 (4.8%) of the 11,319 MRI exams. CDR of the cases and matched control exams for each artifact grade were as follows: mild (n = 238), 0.27 vs 0.25, CDR ratio = 1.09 [95% CI: 0.87-1.37]; moderate (n = 143), 0.18 vs 0.27, CDR ratio = 0.67 [95% CI: 0.46-0.96]; severe (n = 167), 0.22 vs 0.28, CDR ratio = 0.80 [95% CI: 0.59-1.08]. When moderate and severe artifact grades were combined, CDR ratio was 0.74 [95% CI: 0.58-0.93]. CDR reduction was mostly attributed to the increased frequency of PI-RADS 1-2.

CONCLUSION: With moderate to severe susceptibility artifacts from hip prosthesis, CDR was decreased to 74% compared to the matched control.

CLINICAL RELEVANCE STATEMENT: Moderate to severe susceptibility artifacts from hip prosthesis may cause a non-negligible CDR reduction in prostate MRI. Expanding indications for systematic prostate biopsy may be considered when PI-RADS 1-2 was assigned.

KEY POINTS: • We proposed cancer detection rate as a diagnostic performance metric in prostate MRI. • With moderate to severe susceptibility artifacts secondary to hip arthroplasty, cancer detection rate decreased to 74% compared to the matched control. • Expanding indications for systematic prostate biopsy may be considered when PI-RADS 1-2 is assigned.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Nakai H, Takahashi H, Adamo DA, et al. Decreased prostate MRI cancer detection rate due to moderate to severe susceptibility artifacts from hip prosthesis. Eur Radiol. 2023. PMID: 37889268. doi:10.1007/s00330-023-10345-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。